ytterbium has been researched along with Ache in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afarideh, H; Vaez-Tehrani, M; Yousefnia, H; Zolghadri, S | 1 |
Banerjee, S; Chakraborty, S; Das, T; Mathew, B; Pillai, MR; Samuel, G; Sarma, HD; Venkatesh, M | 1 |
2 other study(ies) available for ytterbium and Ache
Article | Year |
---|---|
Human absorbed dose estimation for a new (175)Yb-phosphonate based on rats data: Comparison with similar bone pain palliation agents.
Topics: Animals; Bone Neoplasms; Humans; Organophosphonates; Pain; Pain Management; Radiation Dosage; Rats; Tissue Distribution; Ytterbium | 2016 |
175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
Topics: Animals; Bone and Bones; Bone Neoplasms; Hydrogen-Ion Concentration; Organophosphonates; Pain; Palliative Care; Radiopharmaceuticals; Rats; Rats, Wistar; Spectrometry, Gamma; Tissue Distribution; Ytterbium | 2004 |